Worldwide effort will amass large datasets from institutions that can be used to identify long-term traumatic brain injury and augment therapies.
A substantial international effort, bringing together experts from a variety of specialties, is now in motion with the goal of augmenting the use of MRI to better determine the long-term impacts of traumatic brain injury.
Dubbed ENIGMA, this initiative based at the University of Southern California and conducted in conjunction with the Norwegian University of Science and Technology (NTNU), is designed to collect, combine, and analyze large brain imaging data sets from around the world, searching for connections that cannot be identified on single studies.
The team shared the specifics of this initiative in Brain Imaging and Behavior.
“A major challenge in the research is to figure out which injury characteristics and which changes in the brain caused by the injury can predict how patients will recover and what follow-up they need,” said Alexander Olsen, Ph.D., associate professor of psychology and head of the Clinical Neuroscience Laboratory at NTNU. “A big part of the challenge is that individual patients are so different.”
Related Content: The Value of MRI After Traumatic Brain Injury
Progress into understanding how the brain responds after a traumatic brain injury has been stymied, largely because most previous studies were small and they had no standard way for sharing and analyzing data across institutions because patient populations are heterogenous. The hope now, according to this group comprised of 170 researchers from 13 countries, is that investigations into newer and more advanced MRI methods will provide some clinical benefit.
“By pooling our resources, in terms of data, computational power and intellectual expertise,” said Emily Dennis, Ph.D., co-principal investigator for ENIGMA’s main group on brain injuries, “we’ll be able to tackle some of the big unanswered questions in our field, such as how sex impacts outcome, whether there are subtypes within the broader patient population, or how to handle lesions in neuroimaging data.”
While MRI images can reveal the size and type of injury, Olsen’s group will work with research-based MRI methods that use advanced algorithms and statistics. They intend to apply those methods to MRI data that has already been collected from investigators across the globe, including the United States, Europe, Australia, the Middle East, South Africa, and South America.
“We’re working to develop better and more standardized ways of summarizing and making sense of the MRI data.” Olsen said, noting that only an international collaboration can handle data of this magnitude. “We hope to contribute to breakthroughs in research that will benefit patients.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.